K. Laamanen

A Novel Strategy for Inducing Enhanced Mucosal HIV-1 Antibody Responses in an Anti-Inflammatory Environment

Q. Sattentau, G. Krashias, F. Wegmann, 2011, PloS one.

Isolation of bifidobacteria for blood group secretor status targeted personalised nutrition

P. Wacklin, K. Venema, K. Laamanen, 2012, Microbial ecology in health and disease.

A MICROPARTICLE ENZYME IMMUNOASSAY TO MEASURE SIROLIMUS

D. Holt, K. Laamanen, M. Moreton, 2004, Transplantation proceedings.

Symposium presentations

P. Wacklin, S. Salminen, K. Laamanen, 2012 .

In Vitro Identification and In Vivo Confirmation of Inhibitors for Sweet Potato Chlorotic Stunt Virus RNA Silencing Suppressor, a Viral RNase III

A. Poso, T. Laitinen, J. Valkonen, 2021, Journal of Virology.

Accelerated In Vivo Proliferation of Memory Phenotype CD4+ T-cells in Human HIV-1 Infection Irrespective of Viral Chemokine Co-receptor Tropism

K. Laamanen, C. D. de Lara, P. Beverley, 2013, PLoS pathogens.

Genome-wide siRNA screening reveals several host receptors for the binding of human gut commensal Bifidobacterium bifidum

R. Satokari, R. Kovanen, K. Laamanen, 2022, npj Biofilms and Microbiomes.

A personalised medicine drug sensitivity and resistance testing platform and utilisation of acoustic droplet ejection at the Institute for Molecular Medicine Finland

V. Pietiäinen, K. Wennerberg, K. Laamanen, 2014 .